Amid market resilience, Deven Choksey anticipates Nifty potentially reaching 25,200, with corrections offering buying opportunities. He suggests IT, pharmaceuticals, and metals could drive market momentum, favoring large-cap stocks over mid and small-caps. Controlled input costs and improved capital goods demand may benefit manufacturing, with selective buying advised in IT and pharma stocks.
South Korea’s Kospi rockets 17% after massive 3-day selloff. What’s behind the surge?
The KOSPI was up 17% at 6,549 points after tumbling nearly 17% over the previous three sessions, marking one of its steepest weekly declines, as
July 31, 2026